A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II) by Kenichi Suzuki, Takashi Yokokawa, Takashi Kawaguchi, Shinya Takada, Shinya Tamaki, Yohei Kawasaki, Takumi Yamaguchi, Kei Koizumi, Takuma Matsumoto, Yukio Sakata, Yuichiro Arakawa, Hideaki Ayuhara, Mari Hosonaga, Masakazu Yamaguchi, Daiki Tsuji

Get full text